Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mend
New York, New York, United Statesmend.me ↗
- Ownership
- Private
- Employees
- ~22
- Development stage
- Other
01
Overview
Mend’s programs and nutrapharma products are clinically proven to improve surgical recovery, wound healing, reduce complications, and accelerate return to function; the company partners with hospitals and has published efficacy studies. Their Upgraid platform extends impact through remote nutritional support and behavioral coaching with demonstrated patient and provider benefit.[1][2][4][5][8][9][10]
- Therapeutic areas
- CardiovascularEndocrinologyRheumatologyMetabolic DisordersOtherDermatology
- Modalities
- Medical foodNutraceuticalDigital health intervention
- Industry
- Food & Nutrition
02
Partnerships
OrthoLoneStarLeading hospitals and health systems
Beyond the preview
Go deeper on Mend.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mend.